A family of six high affinity
IGF-binding proteins (IGFBPs 1-6) plays an important role in modulating IGF activities. Recent studies suggest that some IGFBPs may have IGF-independent effects, including induction of apoptosis and modulation of cell migration. However, very little is known about possible IGF-independent actions of
IGFBP-6. We have generated a non-IGF-binding
IGFBP-6 mutant by substituting Ala for four
amino acid residues (Pro(93)/Leu(94)/Leu(97)/Leu(98)) in its N-domain IGF-binding site. A >10,000-fold loss of binding affinity for
IGF-I and
IGF-II was observed using
charcoal solution binding assay, BIAcore biosensor, and
ligand blotting. Wild-type and mutant
IGFBP-6, as well as
IGF-II, induced cell migration in RD
rhabdomyosarcoma and LIM 1215
colon cancer cells. Cell migration was mediated by the C-domain of
IGFBP-6. Transient p38 phosphorylation was observed in RD cells
after treatment with
IGFBP-6, whereas no change was seen in phospho-ERK1/2 levels. Phospho-JNK was not detected. IGFBP-6-induced cell migration was inhibited by
SB203580, an inhibitor of
p38 MAPK, and
PD98059, an inhibitor of ERK1/2 MAPK activation. In contrast,
SP600125, a JNK MAPK inhibitor, had no effect on migration. Knockdown of
p38 MAPK using
short interfering RNA blocked IGFBP-6-induced migration of RD cells. These results indicate that
p38 MAPK is involved in IGFBP-6-induced IGF-independent RD cell migration.